Evidence map›Paper›PMID 25302175›Full record

ReviewWorld journal of clinical oncology2014

Role of IL-10 and TGF-β1 in local immunosuppression in HPV-associated cervical neoplasia.

Kirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina

Open access · hybridAbstract readReview
In one paragraph

Review in World journal of clinical oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Virulence · 2024
    Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Kirvis Torres-PovedaKirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina, Chronic Infection and Cancer Division, Research Center on Infectious Diseases, Instituto Nacional de Salud Pública, 62100 Cuernavaca, Morelos, Mexico.
Margarita Bahena-RománKirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina, Chronic Infection and Cancer Division, Research Center on Infectious Diseases, Instituto Nacional de Salud Pública, 62100 Cuernavaca, Morelos, Mexico.
Claudia Madrid-GonzálezKirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina, Chronic Infection and Cancer Division, Research Center on Infectious Diseases, Instituto Nacional de Salud Pública, 62100 Cuernavaca, Morelos, Mexico.
Ana I Burguete-GarcíaKirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina, Chronic Infection and Cancer Division, Research Center on Infectious Diseases, Instituto Nacional de Salud Pública, 62100 Cuernavaca, Morelos, Mexico.
Víctor Hugo Bermúdez-MoralesKirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina, Chronic Infection and Cancer Division, Research Center on Infectious Diseases, Instituto Nacional de Salud Pública, 62100 Cuernavaca, Morelos, Mexico.
Oscar Peralta-ZaragozaKirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina, Chronic Infection and Cancer Division, Research Center on Infectious Diseases, Instituto Nacional de Salud Pública, 62100 Cuernavaca, Morelos, Mexico.
Vicente Madrid-MarinaKirvis Torres-Poveda, Margarita Bahena-Román, Claudia Madrid-González, Ana I Burguete-García, Víctor Hugo Bermúdez-Morales, Oscar Peralta-Zaragoza, Vicente Madrid-Marina, Chronic Infection and Cancer Division, Research Center on Infectious Diseases, Instituto Nacional de Salud Pública, 62100 Cuernavaca, Morelos, Mexico.
Instituto Nacional de Salud Pública · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer is a worldwide disease that constitutes a significant public health problem, especially in developing countries, not only due to its high incidence but also because the most affected population comprises women who belong to marginalized socio-economic classes. Clinical and molecular research has identified immunological impairment in squamous intraepithelial cervical lesions and cervical cancer patients. Human Papillomavirus (HPV) has several mechanisms for avoiding the immune system: it down-regulates the expression of interferon and upregulates interleukin (IL)-10 and transforming growth factor (TGF)-β1 to produce a local immunosuppressive environment, which, along with altered tumor surface antigens, forms an immunosuppressive network that inhibits the antitumor immune response. In this review we analyzed the available data on several deregulated cellular immune functions in patients with NIC I, NIC II and NIC III and cervical cancer. The effects of immunosuppressive cytokines on innate immune response, T-cell activation and cellular factors that promote tumor cell proliferation in cervical cancer patients are summarized. We discuss the functional consequences of HPV E2, E6, and E7 protein interactions with IL-10 and TGF-β1 promoters in the induction of these cytokines and postulate its effect on the cellular immune response in squamous intraepithelial cervical lesions and cervical cancer patients. This review provides a comprehensive picture of the immunological functions of IL-10 and TGF-β1 in response to HPV in humans.

Indexed as

Cervical cancerHuman PapillomavirusImmunosuppressionInterleukin-10Transforming growth factor-β1

Identifiers

PMID25302175
PMCPMC4129538
OpenAlexW2075865048

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.